DSP 7238
Alternative Names: DSP-7238Latest Information Update: 05 Nov 2023
At a glance
- Originator Dainippon Sumitomo Pharma
- Class Antihyperglycaemics
- Mechanism of Action Dipeptidyl peptidase 4 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 02 Oct 2009 Pharmacokinetics & pharmacodynamics data from in vitro & preclinical trials in Type-2 diabetes mellitus presented at the 45th Annual Meeting of the European Association for the Study of Diabetes (EASD-2009)
- 09 Jun 2009 Preclinical safety, pharmacokinetics and pharmacodynamics data presented at the 69th Annual Scientific Sessions of the American Diabetes Association (ADA-2009) (1132718. 1132719)
- 09 May 2008 Phase-I clinical trials in Type-2 diabetes mellitus in Europe (PO)